Back

Antithrombotic strategies after cryptogenic stroke: a systematic review, pairwise, and network meta-analysis of randomized controlled trials

2 September 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Novel anticoagulants and indications Anticoagulants ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mohamed Abouzid

Poznan University of Medical Sciences, Poznan (Poland)

7 More presentations in this session

Presentation thumbnail
Factor XI activity in ST-segment elevation myocardial infarction
Doctor M. Spagnolo (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus: a meta-analysis of randomized clinical trials
Doctor M. Maqsood (Houston, US)
Abstract Slides Video
Presentation thumbnail
Direct Oral Anticoagulants versus Vitamin K Antagonists for the management of left ventricular thrombus after myocardial infarction: A meta-analysis
Doctor C. Gogos (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Edoxaban for stroke prevention in routine practice patients with atrial fibrillation with and without atherosclerotic disease: a post-hoc sub-study of ETNA-AF-Europe
Doctor T. de Vries (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Unfractionated heparin or low molecular weight heparin in patients with acute pulmonary embolism: a meta-analysis of randomized controlled trials
Doctor M. Maqsood (Houston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Novel anticoagulants and indications

The Event

Event poster

ESC Congress 2024

2 September 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Oral anticoagulants or antiplatelets for cryptogenic stroke: a systematic review and meta-analysis
thumbnail
Congress Presentation
Anticoagulation after embolic stroke of undetermined source - therapeutic dilemmas.
thumbnail
Congress Presentation
Anticoagulation versus antiplatelet therapy in patients with embolic stroke of unknown source: A systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources